{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:33:50Z","timestamp":1787168030706,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To investigate the potential of acute canagliflozin administration to mitigate acute kidney injury (AKI) and attenuate deleterious pro-inflammatory cytokine release in a clinically relevant swine model of severe renal ischemia reperfusion injury (IRI) induced by hemorrhage and aortic occlusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Long-term canagliflozin use attenuates renal function decline and reduces AKI in diabetes mellitus and heart failure patients. While several reports indicate prophylactic SGLT2 inhibition prevents AKI in IRI, the efficacy of acute administration on IRI and inflammation is not known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Female swine (n = 16) underwent controlled hemorrhage of 25% blood volume, followed by 90 min of aortic occlusion at the level of the renal ostia (through resuscitative endovascular balloon occlusion of the aorta). A single 300\u00a0mg dose of oral canagliflozin or vehicle (saline) was delivered 5 mins into aortic occlusion. Hemodynamic monitoring, markers of renal function (serum creatinine, blood urea nitrogen, proteinuria, and urinary neutrophil gelatinase-associated lipocalin), and serum cytokine concentrations [including interleukins (ILs): IL-1RA, IL-6, IL-8, IL-10, IL-18, and tumor necrosis factor\u2013alpha] were analyzed after IRI, and during a 6-hour critical care phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Compared with controls, animals receiving canagliflozin had less severe AKI, improved creatinine clearance, reduced proteinuria, and significantly lower tubular damage as evidenced by histopathology and urinary neutrophil gelatinase-associated lipocalin (NGAL). Furthermore, the pro-inflammatory cytokine IL-6 was markedly attenuated without reduction in anti-inflammatory cytokines (IL-1RA and IL-10).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>A single dose of canagliflozin administered shortly into ischemic insult mitigates AKI and attenuates harmful pro-inflammatory cytokine release after controlled hemorrhage in a swine model. These findings suggest a potential novel therapeutic role for canagliflozin in mitigating the effects of renal IRI worthy of further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/sla.0000000000006501","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:25:56Z","timestamp":1724433956000},"page":"519-527","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Canagliflozin Mitigates Acute Kidney Injury Secondary to Resuscitative Endovascular Balloon Occlusion of the Aorta in a Porcine Model of Hemorrhagic Shock"],"prefix":"10.1097","volume":"283","author":[{"given":"Simon","family":"Tallowin","sequence":"first","affiliation":[{"name":"Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD"},{"name":"Academic Department of Military Surgery and Trauma, Royal Centre for Defence Medicine, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biebele","family":"Abel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brinda","family":"Mysore","sequence":"additional","affiliation":[{"name":"Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mares","sequence":"additional","affiliation":[{"name":"Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Animal Resources, Uniformed Services University of the Health Sciences, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon W.","family":"Propper","sequence":"additional","affiliation":[{"name":"Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD"},{"name":"Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-0158","authenticated-orcid":false,"given":"David M.","family":"Burmeister","sequence":"additional","affiliation":[{"name":"Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD"},{"name":"Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"key":"R1-20260225","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.amjmed.2005.01.069","article-title":"Has mortality from acute renal failure decreased? A systematic review of the literature","volume":"118","author":"Ympa","year":"2005","journal-title":"Am J Med"},{"key":"R2-20260225","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1177\/00031348231157894","article-title":"Acute kidney injury in hypotensive trauma patients following resuscitative endovascular balloon occlusion of the aorta placement","volume":"89","author":"Hunt","year":"2023","journal-title":"Am Surg"},{"key":"R3-20260225","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1001\/jama.2023.20850","article-title":"Emergency department resuscitative endovascular balloon occlusion of the aorta in trauma patients with exsanguinating hemorrhage: the UK-REBOA randomized clinical trial","volume":"330","author":"Jansen","year":"2023","journal-title":"JAMA"},{"key":"R4-20260225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.dsx.2018.06.003","volume":"12","author":"Tsimihodimos","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"R5-20260225","doi-asserted-by":"crossref","first-page":"bvab083","DOI":"10.1210\/jendso\/bvab083","article-title":"Roles of sodium-glucose cotransporter 2 of mesangial cells in diabetic kidney disease","volume":"5","author":"Wakisaka","year":"2021","journal-title":"J Endocr Soc"},{"key":"R6-20260225","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20260225","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"R8-20260225","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/dom.13754","article-title":"Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials","volume":"21","author":"Gilbert","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"R9-20260225","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"R10-20260225","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1681\/ASN.2016030278","article-title":"Canagliflozin slows progression of renal function decline independently of glycemic effects","volume":"28","author":"Heerspink","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R11-20260225","doi-asserted-by":"crossref","first-page":"e1002983","DOI":"10.1371\/journal.pmed.1002983","article-title":"Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: a systematic review and meta-analysis","volume":"16","author":"Menne","year":"2019","journal-title":"PLoS Med"},{"key":"R12-20260225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-020-00732-4","article-title":"Empagliflozin suppresses inflammation and protects against acute septic renal injury","volume":"29","author":"Maayah","year":"2021","journal-title":"Inflammopharmacology"},{"key":"R13-20260225","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41420-021-00801-9","article-title":"Canagliflozin protects against cisplatin-induced acute kidney injury by AMPK-mediated autophagy in renal proximal tubular cells","volume":"8","author":"Park","year":"2022","journal-title":"Cell Death Discov"},{"key":"R15-20260225","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1515\/jccm-2015-0023","article-title":"Plasma neutrophil gelatinase associated lipocalin (NGAL) \u2013 early biomarker for acute kidney injury in critically ill patients","volume":"1","author":"Bianca","year":"2015","journal-title":"J Crit Care Med"},{"key":"R16-20260225","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-022-04223-6","article-title":"Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis","volume":"26","author":"Pan","year":"2022","journal-title":"Crit Care"},{"key":"R17-20260225","doi-asserted-by":"crossref","first-page":"108368","DOI":"10.1016\/j.diabres.2020.108368","article-title":"A systematic review examining the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2is) on biomarkers of inflammation and oxidative stress","volume":"168","author":"Bray","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"R18-20260225","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/postgradmedj-2021-139939","article-title":"Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis","volume":"98","author":"Liu","year":"2022","journal-title":"Postgrad Med J"},{"key":"R19-20260225","first-page":"e0387","article-title":"Accuracy for Mortality prediction with additive biomarkers including interleukin-6 in critically ill patients: a multicenter prospective observational study","volume":"3","author":"Yamamoto","year":"2021","journal-title":"Crit Care Explor"},{"key":"R20-20260225","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/SHK.0b013e3181d8e687","article-title":"Early elevation in random plasma IL-6 after severe injury is associated with development of organ failure","volume":"34","author":"Cuschieri","year":"2010","journal-title":"Shock Augusta Ga"},{"key":"R21-20260225","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00068-017-0880-9","article-title":"Using IL-6 concentrations in the first 24 h following trauma to predict immunological complications and mortality in trauma patients: a meta-analysis","volume":"44","author":"Qiao","year":"2018","journal-title":"Eur J Trauma Emerg Surg"},{"key":"R22-20260225","doi-asserted-by":"crossref","first-page":"e0158810","DOI":"10.1371\/journal.pone.0158810","article-title":"Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"R23-20260225","doi-asserted-by":"crossref","first-page":"19323","DOI":"10.1038\/s41598-022-24103-x","article-title":"Empagliflozin protects against renal ischemia\/reperfusion injury in mice","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"R24-20260225","doi-asserted-by":"crossref","first-page":"113357","DOI":"10.1016\/j.biopha.2022.113357","article-title":"Head-to-head comparison of two SGLT-2 inhibitors on AKI outcomes in a rat ischemia-reperfusion model","volume":"153","author":"Chu","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R25-20260225","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2021.05.005","article-title":"Canagliflozin and kidney-related adverse events in type 2 diabetes and CKD: findings from the randomized CREDENCE trial","volume":"79","author":"Heerspink","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"R26-20260225","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jamasurg.2019.0096","article-title":"Nationwide analysis of resuscitative endovascular balloon occlusion of the aorta in civilian trauma","volume":"154","author":"Joseph","year":"2019","journal-title":"JAMA Surg"},{"key":"R27-20260225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/TA.0000000000001711","article-title":"The pitfalls of resuscitative endovascular balloon occlusion of the aorta","volume":"84","author":"Davidson","year":"2018","journal-title":"J Trauma Acute Care Surg"},{"key":"R28-20260225","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jss.2020.06.042","article-title":"A new pressure-regulated, partial resuscitative endovascular balloon occlusion of the aorta device achieves targeted distal perfusion","volume":"256","author":"White","year":"2020","journal-title":"J Surg Res"},{"key":"R29-20260225","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/TA.0000000000003493","article-title":"Advanced partial occlusion controller allows for increased precision during targeted regional optimization in a porcine model of hemorrhagic shock","volume":"92","author":"Lauria","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"key":"R30-20260225","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/j.injury.2018.09.052","article-title":"Blood pressure targeting by partial REBOA is possible in severe hemorrhagic shock in pigs and produces less circulatory, metabolic and inflammatory sequelae than total REBOA","volume":"49","author":"Sadeghi","year":"2018","journal-title":"Injury"},{"key":"R31-20260225","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.dsx.2018.06.003","article-title":"SGLT2 inhibitors and the kidney: effects and mechanisms","volume":"12","author":"Tsimihodimos","year":"2018","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"R32-20260225","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s00125-014-3396-4","article-title":"Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration","volume":"57","author":"\u0160krti\u0107","year":"2014","journal-title":"Diabetologia"},{"key":"R33-20260225","doi-asserted-by":"crossref","first-page":"F712","DOI":"10.1152\/ajprenal.00264.2020","article-title":"A role for tubular Na+\/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin","volume":"319","author":"Onishi","year":"2020","journal-title":"Am J Physiol-Ren Physiol"},{"key":"R34-20260225","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"R35-20260225","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/dom.13961","article-title":"Interplay of adenosine monophosphate-activated protein kinase\/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: a novel conceptual framework","volume":"22","author":"Packer","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"R36-20260225","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1159\/000489241","article-title":"Current mechanistic concepts in ischemia and reperfusion injury","volume":"46","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R37-20260225","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1177\/039139880402701203","article-title":"Molecular mechanisms of acute renal failure following ischemia\/reperfusion","volume":"27","author":"Versteilen","year":"2004","journal-title":"Int J Artif Organs"},{"key":"R38-20260225","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.3390\/ijms20205034","article-title":"Ischemia\/reperfusion injury revisited: an overview of the latest pharmacological strategies","volume":"20","author":"Soares","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R39-20260225","doi-asserted-by":"crossref","first-page":"109024","DOI":"10.1016\/j.intimp.2022.109024","article-title":"SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis","volume":"110","author":"Long","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R40-20260225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12967-019-1881-8","article-title":"Acute canagliflozin treatment protects against in vivo myocardial ischemia\u2013reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation","volume":"17","author":"Sayour","year":"2019","journal-title":"J Transl Med"},{"key":"R41-20260225","doi-asserted-by":"crossref","first-page":"165770","DOI":"10.1016\/j.bbadis.2020.165770","article-title":"SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models","volume":"1866","author":"Andreadou","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R42-20260225","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3349\/ymj.2022.63.7.619","article-title":"Canagliflozin ameliorates nonalcoholic fatty liver disease by regulating lipid metabolism and inhibiting inflammation through induction of autophagy","volume":"63","author":"Xu","year":"2022","journal-title":"Yonsei Med J"},{"key":"R43-20260225","doi-asserted-by":"crossref","first-page":"e0045","DOI":"10.1097\/HC9.0000000000000045","article-title":"Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1\/2 pathway","volume":"7","author":"Huang","year":"2023","journal-title":"Hepatol Commun"},{"key":"R44-20260225","doi-asserted-by":"crossref","first-page":"121654","DOI":"10.1016\/j.lfs.2023.121654","article-title":"Canagliflozin attenuates thioacetamide-induced liver injury through modulation of HMGB1\/RAGE\/TLR4 signaling pathways","volume":"322","author":"Abdelmageed","year":"2023","journal-title":"Life Sci"},{"key":"R45-20260225","doi-asserted-by":"crossref","first-page":"1081039","DOI":"10.3389\/fendo.2022.1081039","article-title":"Canagliflozin promotes osteoblastic MC3T3-E1 differentiation via AMPK\/RUNX2 and improves bone microarchitecture in type 2 diabetic mice","volume":"13","author":"Song","year":"2022","journal-title":"Front Endocrinol"},{"key":"R46-20260225","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.3390\/ijms22157774","article-title":"The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction following in vitro vascular ischemia\/reperfusion injury in rats","volume":"22","author":"Korkmaz-Ic\u00f6z","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R47-20260225","doi-asserted-by":"crossref","first-page":"101527","DOI":"10.1016\/j.redox.2020.101527","article-title":"Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: role of heme oxygenase-1","volume":"32","author":"Behnammanesh","year":"2020","journal-title":"Redox Biol"},{"key":"R48-20260225","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.drudis.2021.04.007","article-title":"Klotho: a possible mechanism of action of SGLT2 inhibitors preventing episodes of acute kidney injury and cardiorenal complications of diabetes","volume":"26","author":"Kale","year":"2021","journal-title":"Drug Discov Today"},{"key":"R49-20260225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/shk.0b013e31804a5791","article-title":"Uncontrolled hemorrhage differs from volume or pressure-matched controlled hemorrhage in swine","volume":"28","author":"Sondeen","year":"2007","journal-title":"Shock"},{"key":"R50-20260225","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41598-023-28225-8","article-title":"Sex-dependent effects of canagliflozin and dapagliflozin on hemostasis in normoglycemic and hyperglycemic mice","volume":"13","author":"Marci\u0144czyk","year":"2023","journal-title":"Sci Rep"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T22:02:44Z","timestamp":1772056964000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000006501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000006501","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]}}}